Standout Papers

FOLFIRINOX versus Gemcitabine for Metastatic Pancr... 1998 2026 2007 2016 5.4k
  1. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer (2011)
    Thierry Conroy, Françoise Desseigne et al. New England Journal of Medicine
  2. Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102 (2007)
    Laurent Bedenne, Pierre Michel et al. Journal of Clinical Oncology
  3. Risk factors for anastomotic leakage after resection of rectal cancer (1998)
    Éric Rullier, Alexis Laurent et al. British journal of surgery
  4. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy (2007)
    Frédéric Di Fiore, Frédéric Blanchard et al. British Journal of Cancer

Immediate Impact

3 by Nobel laureates 3 from Science/Nature 84 standout
Sub-graph 1 of 17

Citing Papers

Pancreatic cancer
2025 Standout
Oesophageal cancer
2024 Standout
55 intermediate papers

Works of Pierre Michel being referenced

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
2014
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102
2007 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Pierre Michel 8208 4395 4504 256 12.7k
Paul J. Catalano 9442 4737 3356 303 18.2k
Herman R. Menck 5574 3902 4291 131 12.8k
Andrew K. Stewart 7448 4484 5696 165 14.8k
Franck Bonnetain 6336 4081 4500 288 10.9k
James E. Krook 10087 5725 3056 135 14.4k
Farhad Islami 5259 3240 4156 222 16.3k
Janet Dunn 6347 2952 3022 247 10.9k
Marianna Zahurak 6736 4976 5651 220 16.5k
Gregory R. Pond 5537 5526 3186 566 15.4k
V.E.P.P. Lemmens 7197 3834 5509 308 13.5k

All Works

Loading papers...

Rankless by CCL
2026